4.3 Article

Frequency and significance of IgG4 immunohistochemical staining in liver explants from patients with primary sclerosing cholangitis

Journal

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Volume 95, Issue 3, Pages 209-215

Publisher

WILEY
DOI: 10.1111/iep.12076

Keywords

bilary disease; dominant stricture; liver transplantation; pancreatitis

Categories

Funding

  1. Wellcome Trust

Ask authors/readers for more resources

Dense tissue infiltrates of IgG4(+) plasma cells >50/high-powered field (HPF) are purportedly highly specific for IgG4-related disease. However, the frequency and significance of liver-infiltrating IgG4(+) plasma cells in primary sclerosing cholangitis (PSC) applying these cut-offs has not been determined. We sought to determine the incidence of intrahepatic IgG4-positive staining in PSC patients undergoing transplantation, correlating findings with clinical parameters. Immunohistochemical staining was performed on liver explants obtained between 1991 and 2009. Of 122 explants obtained, hilar IgG4(+) staining was found to be mild (10-29 IgG4(+) cells/HPF) in 23.0%, moderate (30-50/HPF) in 9.0% and marked (>50/HPF) in 15.6%. Marked hilar lymphoplasmacytic infiltration was significantly associated with marked hilar IgG4(+) staining (P<0.001). No patient had marked peripheral IgG4(+) staining, although mild and moderate staining was observed in 24.5% and 3.3% respectively. Marked hilar IgG4(+) staining was significantly associated with the presence of dominant biliary strictures (P=0.01) and need for biliary stenting (P=0.001). There did not, however, exist any significant differences in the age at PSC diagnosis, presence of inflammatory bowel disease or extrahepatic autoimmune disease, frequency of cholangiocarcinoma, interval between diagnosis and transplantation, or post-transplant PSC recurrence or survival. Of 51 control liver sections (PBC=18; HCV=19; HBV=8; AIH=6), none had marked or moderate hilar IgG4(+) staining, whereas mild staining was seen in only 10% (P<0.001). Marked (>50/HPF) hilar IgG4(+) lymphoplasmacytic infiltration is frequently observed in PSC and associated with the presence of dominant biliary strictures. However, unlike serum IgG4(,)(+) this does not seemingly associate with clinical disease course.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA

Gideon M. Hirschfield, Ulrich Beuers, Limas Kupcinskas, Peter Ott, Annika Bergquist, Martti Faerkkilae, Michael P. Manns, Albert Pares, Ulrich Spengler, Michael Stiess, Roland Greinwald, Markus Prols, Dominique Wendum, Uta Drebber, Raoul Poupon

Summary: Budesonide did not improve liver histology in patients with PBC who had insufficient response to UDCA, but demonstrated significant improvements in biochemical markers of disease activity.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis

Brian P. Lee, Gene Y. Im, John P. Rice, Ann Lazar, Ethan Weinberg, Hyosun Han, Haripriya Maddur, R. Mark Ghobrial, George Therapondos, Christine Hsu, Oren K. Fix, Sheila Eswaran, Kirti Shetty, Jag Chhatwal, Ozden O. Dalgic, Neha Jakhete, Constance Mobley, David W. Victor, Neil Mehta, Lisanne Dinges, Mary Rinella, Thomas D. Schiano, Michael R. Lucey, Norah Terrault

Summary: Early liver transplantation for alcoholic hepatitis can save lives, but concerns about continued alcohol use exist. This study identified distinct patterns of alcohol use post-transplantation and found that early alcohol use was associated with higher risk of mortality at 3 and 5 years. Pre-transplant characteristics were associated with post-transplant alcohol use patterns, which can inform candidate selection and addiction care after transplantation.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Genetics & Heredity

Clinical-grade whole-genome sequencing and 3′ transcriptome analysis of colorectal cancer patients

Agata Stodolna, Miao He, Mahesh Vasipalli, Zoya Kingsbury, Jennifer Becq, Joanne D. Stockton, Mark P. Dilworth, Jonathan James, Toju Sillo, Daniel Blakeway, Stephen T. Ward, Tariq Ismail, Mark T. Ross, Andrew D. Beggs

Summary: Clinical whole-genome sequencing has the potential to identify private genomic variations that may confer sensitivity to targeted therapies, offering patients new options for treatment.

GENOME MEDICINE (2021)

Editorial Material Gastroenterology & Hepatology

Editorial: liver disease in secondary care-'money or your life'. Authors' reply

Surain B. Roberts, Amol A. Verma, Gideon M. Hirschfield

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Article Gastroenterology & Hepatology

Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort

Surain B. Roberts, Bettina E. Hansen, Saeha Shin, Lusine Abrahamyan, Lauren Lapointe-Shaw, Harry L. A. Janssen, Fahad Razak, Amol A. Verma, Gideon M. Hirschfield

Summary: Liver disease is a growing burden on population health globally, with liver disease patients in Toronto-area hospitals having higher mortality rates and resource use compared to common cardio-respiratory conditions such as heart failure, COPD, and pneumonia. Re-evaluation of approaches to caring for inpatients with liver disease is necessary.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Article Gastroenterology & Hepatology

Recent advances in clinical practice: epidemiology of autoimmune liver diseases

Palak J. Trivedi, Gideon M. Hirschfield

Summary: Autoimmune liver diseases, including primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis, show meaningful changes in disease epidemiology with increasing incidence and prevalence in Europe, North America, and the Asia-Pacific region. Global variations exist in contemporary incidence rates, with age, sex, and race impacting clinical outcomes and the need for gastroenterology, hepatology, and organ transplant services.
Article Gastroenterology & Hepatology

The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single-Center Analysis

Kristel K. Leung, Audrey Kim, Bettina E. Hansen, Les Lilly, Nazia Selzner, Keyur Patel, Mamatha Bhat, Gideon M. Hirschfield, Zita Galvin

Summary: This study analyzed the impact of organ allocation in liver transplantation, finding that patient social determinants and primary liver disease etiology continue to be significantly associated with ultimate transplantation.

LIVER TRANSPLANTATION (2021)

Article Gastroenterology & Hepatology

Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation

Aldo J. Montano-Loza, Vincenzo Ronca, Maryam Ebadi, Bettina E. Hansen, Gideon Hirschfield, Saleh Elwir, Mohamad Alsaed, Piotr Milkiewicz, Maciej K. Janik, Hanns-Ulrich Marschall, Maria Antonella Burza, Cumali Efe, Ali Riza Caliskan, Murat Harputluoglu, Gokhan Kabacam, Debora Terrabuio, Fernanda de Quadros Onofrio, Nazia Selzner, Alan Bonder, Albert Pares, Laura Llovet, Murat Akyildiz, Cigdem Arikan, Michael P. Manns, Richard Taubert, Anna-Lena Weber, Thomas D. Schiano, Brandy Haydel, Piotr Czubkowski, Piotr Socha, Natalia Oldak, Nobuhisa Akamatsu, Atsushi Tanaka, Cynthia Levy, Eric F. Martin, Aparna Goel, Mai Sedki, Irena Jankowska, Toru Ikegami, Maria Rodriguez, Martina Sterneck, Christina Weiler-Normann, Christoph Schramm, Maria Francesca Donato, Ansgar Lohse, Raul J. Andrade, Vilas R. Patwardhan, Bart van Hoek, Maaike Biewenga, Andreas E. Kremer, Yoshihide Ueda, Mark Deneau, Mark Pedersen, Marlyn J. Mayo, Annarosa Floreani, Patrizia Burra, Maria Francesca Secchi, Benedetta Terziroli Beretta-Piccoli, Marco Sciveres, Giuseppe Maggiore, Syed-Mohammed Jafri, Dominique Debray, Muriel Girard, Florence Lacaille, Ellina Lytvyak, Andrew L. Mason, Michael Heneghan, Ye Htun Oo

Summary: Recurrence of autoimmune hepatitis (AIH) is common after liver transplantation, and it is associated with younger age at transplantation, the use of mycophenolate mofetil post-transplant, sex mismatch, and high pre-transplant IgG levels. Recurrent AIH is associated with impaired graft and overall survival. Better characterization, prevention, and treatment strategies are needed for the management of recurrent AIH.

JOURNAL OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis

Christopher L. Bowlus, Michael R. Galambos, Richard J. Aspinall, Gideon M. Hirschfield, David E. J. Jones, Yvonne Doerffel, Stuart C. Gordon, Stephen A. Harrison, Andreas E. Kremer, Marlyn J. Mayo, Paul J. Thuluvath, Cynthia Levy, Mark G. Swain, Guy W. Neff, David A. Sheridan, Carmen M. Stanca, Christoph P. Berg, Aparna Goel, Mitchell L. Shiffman, John M. Vierling, Pol Boudes, Alexandra Steinberg, Yun-Jung Choi, Charles A. McWherter

Summary: This study examined the efficacy and safety of seladelpar in patients with primary biliary cholangitis (PBC). The results showed that seladelpar significantly improved biochemical markers of cholestasis and inflammation, and the improvements were maintained or improved after dose escalation at 52 weeks. The treatment was safe and not associated with worsening pruritus.

JOURNAL OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study

Gideon M. Hirschfield, Mitchell L. Shiffman, Aliya Gulamhusein, Kris Kowdley, John M. Vierling, Cynthia Levy, Andreas E. Kremer, Ehud Zigmond, Pietro Andreone, Stuart C. Gordon, Christopher L. Bowlus, Eric J. Lawitz, Richard J. Aspinall, Daniel S. Pratt, Karina Raikhelson, Maria S. Gonzalez-Huezo, Michael A. Heneghan, Sook-Hyang Jeong, Alma L. Ladron de Guevara, Marlyn J. Mayo, George N. Dalekos, Joost P. H. Drenth, Ewa Janczewska, Barbara A. Leggett, Frederik Nevens, Victor Vargas, Eli Zuckerman, Christophe Corpechot, Eduardo Fassio, Holger Hinrichsen, Pietro Invernizzi, Palak J. Trivedi, Lisa Forman, David E. J. Jones, Stephen D. Ryder, Mark G. Swain, Alexandra Steinberg, Pol F. Boudes, Yun-Jung Choi, Charles A. McWherter

Summary: This study evaluated the efficacy and safety of seladelpar in patients with primary biliary cholangitis who had inadequate response or intolerance to ursodeoxycholic acid. The results showed that seladelpar significantly improved liver biochemistry and pruritus in these patients, and it was well tolerated.

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: A coming of age or an age-ist problem?

Amanda Ricciuto, Binita M. Kamath, Gideon M. Hirschfield, Palak J. Trivedi

Summary: Autoimmune liver diseases are classified into three syndromes, but they are challenging due to variant presentations and lack of definable disease aetiologies. This article argues that "autoimmune sclerosing cholangitis" and "PSC/AIH-overlap" in young patients represent inflammatory phases of primary sclerosing cholangitis and should be considered as the same entity to facilitate unified care and collaborative studies.

JOURNAL OF HEPATOLOGY (2023)

Article Surgery

NHS advice and guidance- improving outpatient flow and patient care in general surgery

Irina Radnaeva, Anitha Muthusami, Stephen Ward

Summary: This study analyzed the use of A&G digital tool for e-referrals in general surgery and evaluated the outcomes and impact on outpatient appointments. The results indicated that A&G requests can reduce the need for outpatient appointments and have a fast response time.

SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND (2023)

Article Gastroenterology & Hepatology

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

Laura Martinez-Gili, Alexandros Pechlivanis, Julie A. K. McDonald, Sofina Begum, Jonathan Badrock, Jessica K. Dyson, Rebecca Jones, Gideon Hirschfield, Stephen D. Ryder, Richard Sandford, Simon Rushbrook, Douglas Thorburn, Simon D. Taylor-Robinson, Mary M. E. Crossey, Julian R. Marchesi, George Mells, Elaine Holmes, David Jones

Summary: A study on patients with primary biliary cholangitis (PBC) showed that there is variation in response to ursodeoxycholic acid (UDCA) treatment. Responders exhibited high levels of secondary and tertiary bile acids, while non-responders had lower urinary bile acid levels and higher levels of 12-dehydrocholic acid. Additionally, non-responders showed lower gut microbiota diversity and lower capacity for bile acid deconjugation.

GUT MICROBES (2023)

Article Urology & Nephrology

Responsiveness to Vasoconstrictor Therapy in Hepatorenal Syndrome Type 1

Juan Carlos Q. Velez, Nithin Karakala, Kasra Tayebi, Terrance J. Wickman, Muner M. B. Mohamed, Rosemary A. Kovacic, George Therapondos, Swetha R. Kanduri, Andrew S. Allegretti, Justin M. Belcher, Kevin R. Regner, Cathy Wentowski

Summary: Raising the mean arterial pressure (MAP) during management of hepatorenal syndrome type 1 (HRS-1) is associated with improvement in kidney function, and raising the MAP by 15 mm Hg or greater leads to greater reduction in serum creatinine. Use of norepinephrine confers greater probability of improvement in kidney function compared with midodrine/octreotide.

KIDNEY360 (2023)

Article Surgery

CT angiograms for lower GI bleeding: the experience of a large UK teaching hospital

S. Snelling, R. Ghaffar, S. T. Ward

Summary: This study aimed to assess the use and role of CT-A in diagnosing LGIB. The findings showed that CT-A has a relatively low pick up rate of active bleeding, but it still plays an important role in the investigation of LGIB.

ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (2022)

No Data Available